Cost and Utility in Recipients of Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT) Who Developed Herpes Zoster (HZ) During the Phase 3 Trial of Inactivated Varicella-Zoster Vaccine (ZVIN)
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1102
https://www.valueinhealthjournal.com/article/S1098-3015(18)31405-0/fulltext
Title :
Cost and Utility in Recipients of Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT) Who Developed Herpes Zoster (HZ) During the Phase 3 Trial of Inactivated Varicella-Zoster Vaccine (ZVIN)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31405-0&doi=10.1016/j.jval.2018.04.1102
First page :
Section Title :
Open access? :
No
Section Order :
340